.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
US Army
Julphar
Express Scripts
AstraZeneca
QuintilesIMS
Cipla
Daiichi Sankyo
Baxter
Healthtrust

Generated: September 20, 2017

DrugPatentWatch Database Preview

CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE Drug Profile

« Back to Dashboard

What is the patent landscape for Codeine Phosphate And Chlorpheniramine Maleate, and what generic Codeine Phosphate And Chlorpheniramine Maleate alternatives are available?

Codeine Phosphate And Chlorpheniramine Maleate is a drug marketed by Spriaso Llc and is included in one NDA. There are four patents protecting this drug.

This drug has fifty-six patent family members in eleven countries.

The generic ingredient in CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE is chlorpheniramine maleate; codeine phosphate. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorpheniramine maleate; codeine phosphate profile page.

Summary for Tradename: CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE

Patents:4
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list106,479
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE at DailyMed

Pharmacology for Tradename: CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Spriaso Llc
CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate; codeine phosphate
TABLET, EXTENDED RELEASE;ORAL206323-001Jun 22, 2015DISCNNoNo► Subscribe► SubscribeY ► Subscribe
Spriaso Llc
CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate; codeine phosphate
TABLET, EXTENDED RELEASE;ORAL206323-001Jun 22, 2015DISCNNoNo► Subscribe► Subscribe ► Subscribe
Spriaso Llc
CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate; codeine phosphate
TABLET, EXTENDED RELEASE;ORAL206323-001Jun 22, 2015DISCNNoNo► Subscribe► SubscribeY ► Subscribe
Spriaso Llc
CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate; codeine phosphate
TABLET, EXTENDED RELEASE;ORAL206323-001Jun 22, 2015DISCNNoNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,098,581Spark plug► Subscribe
7,309,951Spark plug► Subscribe
2,015,224,130► Subscribe
6,451,339 Compositions and methods for improved delivery of hydrophobic agents► Subscribe
6,309,663 Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents► Subscribe
7,374,779Pharmaceutical formulations and systems for improved absorption and multistage release of active agents► Subscribe
6,294,192 Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents► Subscribe
6,982,281Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs► Subscribe
6,761,903 Clear oil-containing pharmaceutical compositions containing a therapeutic agent► Subscribe
6,923,988 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE

Country Document Number Estimated Expiration
Canada2375083► Subscribe
Australia780877► Subscribe
Australia5313100► Subscribe
Japan2012116863► Subscribe
World Intellectual Property Organization (WIPO)2004087052► Subscribe
World Intellectual Property Organization (WIPO)0059475► Subscribe
World Intellectual Property Organization (WIPO)2004105694► Subscribe
Japan2003517470► Subscribe
Australia771659► Subscribe
World Intellectual Property Organization (WIPO)2007018943► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Cantor Fitzgerald
Chinese Patent Office
Fish and Richardson
Accenture
Citi
Dow
US Army
Chubb
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot